B Cell Repopulation and Rheumatoid Factor Predict Duration of Response to Rituximab in Rheumatoid Arthritis

被引：0
|
作者：
Vital, Edward M. [1 ,2 ]
Das, Sudipto [2 ,3 ]
Dass, Shouvik [1 ,2 ]
Buch, Maya H.
Ponchel, Frederique [1 ,2 ]
Rawstron, Andrew [1 ,2 ]
Emery, Paul [1 ,4 ]
机构：
[1] Univ Leeds, NIHR Leeds Biomed Res Unit, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[3] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England
[4] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1643
引用
收藏
页码：S642 / S642
页数：1
相关论文
共 50 条
  • [21] Relationship between clinical response, rituximab pharmacokinetics and peripheral B cell levels in rheumatoid arthritis
    Breedveld, F. C.
    Agarwal, S.
    Yin, M.
    Ng, C.
    Li, N. F.
    Shaw, T. M.
    Davies, B. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 179 - 179
  • [22] Rituximab - In rheumatoid arthritis
    Frampton, James E.
    Scott, Lesley J.
    [J]. BIODRUGS, 2007, 21 (05) : 333 - 341
  • [23] Rituximab for rheumatoid arthritis
    Lopez-Olivo, Maria Angeles
    Urruela, Matxalen Amezaga
    McGahan, Lynda
    Pollono, Eduardo N.
    Suarez-Almazor, Maria E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (01):
  • [24] Rituximab for Rheumatoid Arthritis
    Cohen M.D.
    Keystone E.
    [J]. Rheumatology and Therapy, 2015, 2 (2) : 99 - 111
  • [25] Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience
    Salgado, Eva
    Campos, Jose
    Moreira-Navarrete, Virginia
    Mulero, Juan
    Navarro, Federico
    Perez-Pampin, Eva
    Carmoa, Loreto
    Gomez-Reino, Juan
    [J]. JOINT BONE SPINE, 2013, 80 (04) : 438 - 440
  • [26] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    John D Hainsworth
    [J]. Arthritis Res Ther, 5
  • [27] Efficacy of B-cell-targeted therapy with rituximab in rheumatoid arthritis
    Larry Moreland
    [J]. Current Rheumatology Reports, 2005, 7 (5) : 380 - 380
  • [28] Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis
    Hainsworth, JD
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 4) : S12 - S16
  • [29] Alteration of B cell phenotype following depletion with rituximab in rheumatoid arthritis
    Burgoyne, C.
    Vital, E.
    Dass, S.
    Corscadden, D.
    Emery, P.
    Ponchel, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 : A5 - A6
  • [30] Rheumatoid factor as predictor of response to abatacept, rituximab and tocilizumab in rheumatoid arthritis: Systematic review and meta-analysis
    Maneiro, R. J.
    Salgado, Eva
    Carmona, Loreto
    Gomez-Reino, Juan J.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2013, 43 (01) : 9 - 17
12345